Brain entangled in prescription bottles, symbolizing mental health treatment complexities.

Rethinking Antipsychotics: A New Look at Usage in Adults with Intellectual and Developmental Disabilities

Samir D’Costa in Health & Wellness June 2025 • 4 min read.

"Is there a disconnect between diagnosis and prescription? Uncover the concerning trends in antipsychotic medication use among vulnerable adults and what it means for better care."

Antipsychotic medications play a significant role in managing various psychiatric conditions, but their use remains a subject of debate, especially when it comes to individuals with intellectual and developmental disabilities (IDD). While these medications can be effective in treating specific mental health disorders, concerns arise when they're prescribed without a clear psychiatric diagnosis. This is particularly troubling given the potential for adverse side effects and the need for careful monitoring.

Recent research has shed light on the prevalence of antipsychotic use among adults with IDD, revealing some surprising trends. One key finding is that a significant number of individuals with IDD are receiving these medications without a documented psychiatric diagnosis. This raises questions about the reasons behind these prescriptions and whether they align with best practices in patient care.

Understanding the appropriate use of antipsychotics in adults with IDD requires a closer examination of the factors driving these prescribing patterns. It's crucial to consider the potential risks and benefits, as well as the availability of alternative treatments and support services. By addressing these issues, healthcare professionals can work towards ensuring that individuals with IDD receive the most effective and appropriate care.

The Disconnect: Antipsychotic Use Without Psychiatric Diagnosis

Brain entangled in prescription bottles, symbolizing mental health treatment complexities.

A population-based study in Ontario, Canada, examined antipsychotic use among 51,881 adults with IDD. The study revealed that 39.2% of these adults were dispensed antipsychotic medications. What's particularly striking is that almost one-third (28.91%) of those prescribed antipsychotics did not have a documented psychiatric diagnosis.

This finding underscores a significant concern about the potential for inappropriate or off-label use of these medications. It raises the question of why individuals with IDD are receiving antipsychotics in the absence of a clear psychiatric condition. Some possible explanations include:

Misdiagnosis: Difficulties in accurately diagnosing psychiatric conditions in individuals with IDD may lead to misdiagnosis and inappropriate prescribing.
Behavioral Management: Antipsychotics may be used to manage challenging behaviors associated with IDD, even in the absence of a formal psychiatric diagnosis.
Lack of Alternatives: Limited access to non-pharmacological interventions, such as behavioral therapy, may contribute to reliance on medication.
Systemic Factors: Staffing shortages and environmental characteristics in residential care settings may influence prescribing practices.

The study also found that those without a psychiatric diagnosis differed considerably from those with a diagnosis. In particular, they were older, less likely to have used antidepressants or benzodiazepines, and less likely to have used ambulatory and acute care. These differences highlight the need for a more nuanced understanding of the factors influencing antipsychotic use in this population.

Ensuring Appropriate Prescribing and Monitoring

The findings from this study emphasize the need for increased attention to how antipsychotics are prescribed and monitored for people with IDD in Canada. This includes implementing strategies to improve diagnostic accuracy, promote the use of non-pharmacological interventions, and address systemic factors that may contribute to inappropriate prescribing. By prioritizing these efforts, healthcare professionals can work towards ensuring that individuals with IDD receive the most effective and appropriate care, tailored to their specific needs and circumstances.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is the main concern regarding the use of antipsychotics in adults with Intellectual and Developmental Disabilities (IDD)?

The primary concern is the prescription of antipsychotic medications without a corresponding psychiatric diagnosis. Research indicates that a significant percentage of adults with IDD are receiving these medications even when a clear psychiatric condition isn't documented. This raises questions about the appropriateness of the prescribing practices and the potential for adverse effects on the individuals' health and well-being. This is especially concerning because of the potential for adverse side effects and the need for careful monitoring when using these medications.

What were the key findings of the Ontario, Canada study on antipsychotic use among adults with IDD?

The Ontario study revealed that a substantial proportion of adults with IDD (39.2%) were dispensed antipsychotic medications. A concerning aspect of the study was that nearly one-third (28.91%) of those prescribed antipsychotics did not have a documented psychiatric diagnosis. The study also found differences between those with and without a psychiatric diagnosis, including age, use of other medications, and healthcare utilization. These findings underscore the need for a deeper understanding of the factors influencing antipsychotic use in this population.

What are some of the potential reasons behind the prescription of antipsychotics to adults with IDD without a psychiatric diagnosis?

Several factors may contribute to this trend. These include potential for misdiagnosis of psychiatric conditions in individuals with IDD. Antipsychotics might be used for behavioral management, even in the absence of a formal diagnosis. Limited access to non-pharmacological interventions, like behavioral therapy, could also contribute to the reliance on medication. Additionally, systemic issues, such as staffing shortages or specific environmental characteristics in residential care settings, may also affect prescribing practices.

How does the article suggest improving the use of antipsychotics for individuals with IDD?

The article emphasizes the need for a multi-faceted approach. This includes improving diagnostic accuracy to ensure appropriate treatment, promoting the use of non-pharmacological interventions, and addressing the systemic factors that influence prescribing practices. This will help to ensure that individuals with IDD receive the most effective and suitable care tailored to their unique needs and circumstances. It's also important to ensure that healthcare professionals are adequately trained and supported in their efforts to provide appropriate care.

Why is it crucial to address the disconnect between diagnosis and prescription of antipsychotics for adults with IDD?

Addressing this disconnect is vital to improve the quality of care and protect the well-being of individuals with IDD. Inappropriate or off-label use of antipsychotics can lead to adverse side effects, impacting physical and mental health. By ensuring accurate diagnosis, promoting the use of alternative treatments, and addressing systemic factors, healthcare providers can work towards delivering the most effective, appropriate, and individualized care. This approach not only improves health outcomes but also upholds the ethical standards of healthcare practice.